1-3 of 3
Jacqueline Buchanan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trends in the Multiple Myeloma Treatment Landscape: A United States Analysis of Oscer Electronic Health Record Data 2011-2019

Megan Braunlin, MPH, Rajesh Belani, MD, Jacqueline Buchanan, John Travis Wheeling, MPH, Christopher Kim, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4722.
https://doi.org/10.1182/blood-2019-125972
Published: 2019
Journal Articles

Economic Burden of Disease Progression Among Transplant Eligible Multiple Myeloma Patients Who Have Received at Least One Line of Therapy in the US

Rafael Fonseca, MD, May Hagiwara, PhD, Sumeet Panjabi, PhD, Emre Yucel, PhD MSc, MBA, BSPharm, Jacqueline Buchanan, Thomas Delea, MBA
Journal: Blood
Blood (2019) 134 (Supplement_1): 2211.
https://doi.org/10.1182/blood-2019-123743
Published: 2019
Journal Articles

Health Related Quality of Life Results from the Open-Label, Randomized, Phase III Endeavor Trial Evaluating Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

Heinz Ludwig, Philippe Moreau, Meletios A Dimopoulos, Maria-Victoria Mateos, Martin F Kaiser, MD, Shibao Feng, Kim Cocks, Jacqueline Buchanan, Katja Weisel, MD
Journal: Blood
Blood (2016) 128 (22): 3309.
https://doi.org/10.1182/blood.V128.22.3309.3309
Published: 2016